Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |